Tomoyuki Aoyama

931 total citations
38 papers, 652 citations indexed

About

Tomoyuki Aoyama is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Tomoyuki Aoyama has authored 38 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Tomoyuki Aoyama's work include Sarcoma Diagnosis and Treatment (11 papers), Barrier Structure and Function Studies (10 papers) and Cancer-related molecular mechanisms research (7 papers). Tomoyuki Aoyama is often cited by papers focused on Sarcoma Diagnosis and Treatment (11 papers), Barrier Structure and Function Studies (10 papers) and Cancer-related molecular mechanisms research (7 papers). Tomoyuki Aoyama collaborates with scholars based in Japan and United Kingdom. Tomoyuki Aoyama's co-authors include Tadashi Hasegawa, Shintaro Sugita, Akira Takasawa, Makoto Osanai, Kumi Takasawa, Hiroko Asanuma, Masaki Murata, Makoto Emori, Norimasa Sawada and Yasuhito Arai and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and American Journal Of Pathology.

In The Last Decade

Tomoyuki Aoyama

36 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoyuki Aoyama Japan 14 306 229 188 124 113 38 652
Céline Brulard France 11 289 0.9× 139 0.6× 165 0.9× 20 0.2× 60 0.5× 17 514
Rongkui Luo China 14 227 0.7× 169 0.7× 187 1.0× 17 0.1× 35 0.3× 83 713
Yusuke Okuda Japan 11 91 0.3× 187 0.8× 136 0.7× 28 0.2× 33 0.3× 32 539
Hernan G. Vasquez United States 9 194 0.6× 215 0.9× 321 1.7× 14 0.1× 20 0.2× 15 820
Kim Zuidwijk Netherlands 11 81 0.3× 176 0.8× 250 1.3× 16 0.1× 50 0.4× 13 777
Daisuke Obinata Japan 21 324 1.1× 192 0.8× 483 2.6× 23 0.2× 155 1.4× 63 1.0k
Tetsukan Woo Japan 19 374 1.2× 355 1.6× 378 2.0× 15 0.1× 28 0.2× 42 880
Alei Feng China 14 147 0.5× 261 1.1× 168 0.9× 11 0.1× 59 0.5× 27 686
Qihang Yuan China 19 310 1.0× 288 1.3× 313 1.7× 14 0.1× 44 0.4× 45 780
Chul-Soo Cho South Korea 14 83 0.3× 142 0.6× 278 1.5× 13 0.1× 193 1.7× 15 816

Countries citing papers authored by Tomoyuki Aoyama

Since Specialization
Citations

This map shows the geographic impact of Tomoyuki Aoyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Aoyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Aoyama more than expected).

Fields of papers citing papers by Tomoyuki Aoyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyuki Aoyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Aoyama. The network helps show where Tomoyuki Aoyama may publish in the future.

Co-authorship network of co-authors of Tomoyuki Aoyama

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Aoyama. A scholar is included among the top collaborators of Tomoyuki Aoyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Aoyama. Tomoyuki Aoyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takasawa, Akira, Kumi Takasawa, Tomoyuki Aoyama, et al.. (2024). Multilayered proteomics reveals that JAM‐A promotes breast cancer progression via regulation of amino acid transporter LAT1. Cancer Science. 115(9). 3153–3168. 4 indexed citations
2.
Takasawa, Akira, Yusuke Ono, Tomoyuki Aoyama, et al.. (2023). Invasive pulmonary aspergillosis with candidiasis: usefulness of molecular and ultrastructural morphological analysis on FFPE tissue for invasive fungal infections. Medical Molecular Morphology. 56(2). 144–151. 2 indexed citations
3.
Takasawa, Akira, Kumi Takasawa, Taro Murakami, et al.. (2022). Aberrant expression of claudin‐6 contributes to malignant potentials and drug resistance of cervical adenocarcinoma. Cancer Science. 113(4). 1519–1530. 15 indexed citations
4.
Sugita, Shintaro, Tomoyuki Aoyama, Hiromi Fujita, et al.. (2022). Usefulness of SynCAM3 and cyclin D1 immunohistochemistry in distinguishing superficial CD34-positive fibroblastic tumor from its histological mimics. Medical Molecular Morphology. 56(1). 69–77. 3 indexed citations
5.
Takasawa, Akira, Kumi Takasawa, Tomoyuki Aoyama, et al.. (2022). Pathological classification of desmoplastic reaction is prognostic factor in cervical adenocarcinoma. Medical Molecular Morphology. 55(4). 275–282. 2 indexed citations
6.
Takasawa, Kumi, Akira Takasawa, Tomoyuki Aoyama, et al.. (2021). Regulatory roles of claudin-1 in cell adhesion and microvilli formation. Biochemical and Biophysical Research Communications. 565. 36–42. 13 indexed citations
7.
Kyuno, Daisuke, Akira Takasawa, Kumi Takasawa, et al.. (2021). Claudin-18.2 as a therapeutic target in cancers: cumulative findings from basic research and clinical trials. Tissue Barriers. 10(1). 1967080–1967080. 58 indexed citations
8.
Murakami, Taro, Akira Takasawa, Kumi Takasawa, et al.. (2020). Aberrant expression of junctional adhesion molecule‐A contributes to the malignancy of cervical adenocarcinoma by interaction with poliovirus receptor/CD155. Cancer Science. 112(2). 906–917. 9 indexed citations
9.
Saito, Yuki, Akira Takasawa, Kumi Takasawa, et al.. (2020). Aldolase A promotes epithelial‐mesenchymal transition to increase malignant potentials of cervical adenocarcinoma. Cancer Science. 111(8). 3071–3081. 42 indexed citations
10.
11.
Suzuki, Hime, Nobuhiro Mikuni, Shintaro Sugita, et al.. (2020). Molecular Aberrations Associated with Seizure Control in Diffuse Astrocytic and Oligodendroglial Tumors. Neurologia medico-chirurgica. 60(3). 147–155. 6 indexed citations
12.
13.
Murata, Masaki, Makoto Osanai, Akira Takasawa, et al.. (2018). Occludin induces microvillus formation via phosphorylation of ezrin in a mouse hepatic cell line. Experimental Cell Research. 366(2). 172–180. 3 indexed citations
14.
Aoyama, Tomoyuki, Akira Takasawa, Masaki Murata, et al.. (2018). Immunoreactivity patterns of tight junction proteins are useful for differential diagnosis of human salivary gland tumors. Medical Molecular Morphology. 52(1). 23–35. 12 indexed citations
15.
Takasawa, Akira, Kumi Takasawa, Tomoyuki Aoyama, et al.. (2018). Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression. Neoplasia. 20(10). 1083–1093. 34 indexed citations
16.
Takasawa, Akira, Kumi Takasawa, Tomoyuki Aoyama, et al.. (2017). Prognostic significance of the co-expression of EGFR and HER2 in adenocarcinoma of the uterine cervix. PLoS ONE. 12(8). e0184123–e0184123. 18 indexed citations
17.
Takasawa, Kumi, Akira Takasawa, Makoto Osanai, et al.. (2017). Claudin-18 coupled with EGFR/ERK signaling contributes to the malignant potentials of bile duct cancer. Cancer Letters. 403. 66–73. 36 indexed citations
18.
Sugita, Shintaro, Yasuhito Arai, Tomoyuki Aoyama, et al.. (2017). NUTM2A-CIC fusion small round cell sarcoma: a genetically distinct variant of CIC-rearranged sarcoma. Human Pathology. 65. 225–230. 50 indexed citations
19.
Sugita, Shintaro, Hiroshi Hirano, Noriaki Kikuchi, et al.. (2016). Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics. Diagnostic Pathology. 11(1). 75–75. 46 indexed citations
20.
Sugita, Shintaro, Tomoyuki Aoyama, Jiro Ogino, et al.. (2014). Diagnostic utility of NCOA2 fluorescence in situ hybridization and Stat6 immunohistochemistry staining for soft tissue angiofibroma and morphologically similar fibrovascular tumors. Human Pathology. 45(8). 1588–1596. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Céline Brulard Breakdown of academic impact, for papers by Rongkui Luo Breakdown of academic impact, for papers by Yusuke Okuda Breakdown of academic impact, for papers by Hernan G. Vasquez Breakdown of academic impact, for papers by Kim Zuidwijk Breakdown of academic impact, for papers by Daisuke Obinata Breakdown of academic impact, for papers by Tetsukan Woo Breakdown of academic impact, for papers by Alei Feng Breakdown of academic impact, for papers by Qihang Yuan Breakdown of academic impact, for papers by Chul-Soo Cho
Rankless by CCL
2026